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Gaucher's disease in the Cape. Coloured
population of the RSA, including a
family with 5 affected siblings
A. L. SWART, P. B. HESSELlNG, M. R. HAYDEN, M. LOUW, J. S. HERBERT
Summary
Nine Cape Coloured children from 4 families with
severe non-neuropathic Gaucher's disease are
documented. The diagnosis was confirmed histo-
logically in the bone marrow, spleen ana liver, and
by serum acid phosphatase and leucocyte j:l-glucosi-
dase assays. This represents a minimum prevalence
for Gaucher's disease of 1 in 247350 in this popula-
tion and an approximate genetic carrier rate of 1 .in
230'for the abnormal gene. A family with 5 affected
siblings is recorded. # ~
The severe early clinical expression documented
in tHese coloured patients is similar to that descri~
in fhe AtriKaner popul~tion and differs from the less
severe expression of Gaucher's disease in the South
African Ashkenazi Jewish population. Gaucher's
disease in the Cape Coloured population presents
with a precocious onset, causes severe complications
and progresses rapidly.
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Philippe Gaucher first reported a patient with hepatospleno-
megaly and bone involvement in 1882. 1 The basic defect was
elucidated 83 years later by Brady et al., 2 who demonstrated a
deficiency of j:l-glucosidase in an affected adult, with resulting
accumulation of glucocerebrosides in various tissues, particu-
larly the reticulo-endothelial system.
Gaucher's disease is conventionally classified into the adult
or chronic non-neuropathic type, the acute neuropathic infantile
type and the subacute neuropathic juvenile type. 3 The latter
two conditions lead to death in childhood due to the accumula-
tion of glucocerebrosides in the brain, while the adult or non-
neuropathic form is characterised by a slowly progressive course
marked by massive splenomegaly, dyshaemopoiesis and ortho-
paedic complications.
Chronic non-neuropathic Gaucher's disease has been
reported in adults of Ashkenazi Jewish descent4 in the RSA.
Goldblatt and Beighton5 also documented the presence of a
more severe form of the disease among children of the Afrikaner
population. The same authors recorded non-neuropathic Gau-
cher's disease presenting in infancy in 12 children,6 3 of whom
were of mixed ethnic ancestry and who are included in this
report.
Patients and methods
The patients reported here represent all the cases of Gaucher's
disease diagnosed at Tygerberg Hospital between 1971 and 1984.
During this period the interest of the investigators in this disease
became known and patients with suspected Gaucher's disease
were referred for opinion.
Each patient was examined clinically. A radiological skeletal
survey was performed and the serum acid phosphatase level
measured in 8 patients. Bone marrow aspirate was obtained in 7
patients. The spleen was examined histologically after splenectomy
in 7 patients and liver biopsy was performed on 4 patients. The·
typical electron microscopic appearance of Gaucher cells in the
liver is illustrated in Fig. 1. Leucocyte ,B-glucosidase activity at
pH 5,5 was measured in 4 affected siblings (patients 6 - 9), their
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bleeds as a result of hypersplenism. Patients I - 8 had marked
hepatomegaly.
Intermittent bone pain, present in 5 of the 9 children, was due
to orthopaedic complications which included aseptic necrosis of
the femoral head in 4 patients, pseudo-osteomyelitis in 3 patients
and a pathological fracture of the femur in 2 patients. One patient
now has a shortened leg. The nervous system and eyes were
normal in all patients. There was no history of parenteral consan-
guinity. Patients I and 2 have 4 unaffected sibs, patient 3 is an
only child, as was patient 4, and patients 5 - 9 have two unaffected
sibs.
An autopsy on patient 4, who died of cardiac failure, revealed
no infiltration of the myocardium by Gaucher cells.
Fig. 2. Leucocyte j3-glucosidase activity at pH 5,5 in a family with
5 sibs with Gaucher's disease.
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Fig. 1. The ultra-structural studies demonstrate spindle or rod-
shaped membrane-bound cytoplasmic inclusions typical of Gau-
cher's disease in the liver (plate magnification = 10000; print
magnification = 40000).
parents, a normal sib and in 7 controls according to the method
used by Galjaard. 7 The criterion for hypersplenism was a decreased
peripheral red cell, white cell or platelet count in the presence of
normal haematopoiesis in the bone marrow. The minimum preva-
lence of Gaucher's disease in this population was calculated by
dividing the total Cape Coloured population (as recorded in the
1980 census) by the number of affected patients.
The leucocyte ,B-glucosidase activity is shown in Fig. 2 and all the
laboratory investigations are listed in Table 1.
Nine affected children, 4 boys and 5 girls, were identified. It
was discovered that a sister of the 4 sibs with decreased leucocYte
,B-glucosidase activity had had massive hepatosplenomegaly. She
died of presumed splenic rupture secondary to Gaucher's disease
before this family came to our notice. Hepatosplenomegaly was
very prominent in 8 of the patients. The clinical features of these
children are presented in Table 11. The age at diagnosis varied
from 5 months to 9 years. All the patients except the youngest
(patient 9) had massive splenomegaly and some suffered nose
Discussion
The assignment of Gaucher patients, especially children, to a
clinical subtype should be made only after careful exami~ation
for the presence or absence of neurological signs.
The estimated number of the Cape Coloured population is
2226160 (according to the 1980 census). Nine affected mem-
bers in this group therefore gives a minimum prevalence for
Gaucher's disease of I in 247350; a minimum gene frequency
of 0,0017 with a carrier rate of 0,0034. Therefore, there are
TABLE I. SPECIAL INVESTIGATIONS.
Acid Phos. Leucocyte B- Histology
Patient Hypersplenism (IU/I)* glucocerebrosides Skeletal changes Bone marrow Spleen Liver
+ 44 Unknown Erosion femoral + + +
head
2 , 45 Unknown Erosion femoral + + +T
head
3 + 15,9 Unknown Erosion femoral + + Not performed
head
4 + 35,6 Unknown Erosion femoral + + +
head
5 Not examined Unknown Erosion femoral Unknown Unknown Unknown
head
6 + 161,6 Absent + + Not performed
7 + 67,7 Absent + + Not performed
8 + 163 Absent + + +
9 20,2 Absent Not performed Not performed Not performed
*Normal range 4,8· 13,51U/1.
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TABLE 11. CLINICAL FEATURES IN 9 COLOURED PATIENTS WITH GAUCHER'S DISEASE
Patient Sex Year of birth Presenting symptom Age at diagnosis (yrs) Splenectomy Current status
1 F 1964 Painful hip 5 1970 Died septicaemia, 1970*
2 M 1968 Painful leg 4 1972 Hepatomegaly, bony lesions
3 F 1962 Painful hip 9 1972 Shortened right leg
4 M 1974 Painful hip 1Y2 1978 Died cardiac failure, 1979
5 F 1967 Painlulleg 8 Died splenic rupture, 1979
6 M 1972 Nose bleed 4 1979 Hepatomegaly, otherwise well
7 M 1973 Nose bleed 3 1979 Hepatomegaly, otherwise well
8 F 1976 Splenomegaly 2 1983 Hepatomegaly, otherwise well
9 F 1983 5/12 Asymptomatic
-Did not receive pneumococcal vaccine.
approximately 9600 clinically asymptomatic carriers of the
gene in the Cape Coloured population, i.e. 1 in 230 individuals.
This survey reveals an unexpectedly high frequency of
adult-type non-neuropathic Gaucher's disease of precocious
onset and rapidly progressive course in Cape Coloured children.
One family with a hitherto unrecorded number of 5 affected
sibs is included in this series. Non-neuropathic Gaucher's
disease in this population differs markedly from non-neuro-
pathic Gaucher's disease in adult Ashkenazi Jewish patients
and is similar to non-neuropathic Gaucher's disease in the
Afrikaner population.
All the children in this study had surnames denoting Dutch
ancestry. It is therefore likely that the same genetic factors
causing a progressive form of the disease in the Afrikaner
population are present in this coloured population. These
findings provide evidence that the d~sease in these laner
groups may be due to a different gene from that in the
Ashkenazi Jewish population. This is difficult to explain at
present in view of the similar biochemical findings in all three
population groups.
The.chronic non-neuropathic type was previously designated
the 'adult' form of Gaucher's disease. It is becoming increas-
ingly apparent, however, that many patients with onset of
signs and symptoms early in childhood belong to this group.
The initial signs of this chronic form are usually splenomegaly
(although exceptions have been noted), haematological abnor-
malities attributable to hypersplenism; and bone lesions. The
central nervous system is not affected. The course in adult
non-neuropathic Gaucher's disease is usually slowly progressive
with complications appearing or worsening over a period of
years. It is clear that Gaucher's disease in the children of this
study does not follow this pattern, thus emphasising the
limitations of the original subdivisions of the disease and the
need for its reclassification.
Gaucher's disease results from a deficiency of the enzyme
j3-g1ucosidase which catalyses the cleavage of glucose from
glucocerebrosides, and this defect has been demonstrated in
various tissues. Assay of enzyme activity in peripheral blood
leucocytes may confirm the diagnosis in suspected cases as in
our patient 9, who is still asymptomatic.
The identification of heterozygotes and the prenatal diagnosis
of Gaucher's disease from amniotic cell cultures have permitted
genetic counselling to families at risk, since all three types of
the disease are inherited as an autosomal recessive trait.
Since all but one of the patients had rapid progression of
disease with massive splenomegaly, splenectomy was performed
in all because of considerable physical discomfort, the presence
of hypersplenism and the danger of splenic rupture. All but
the first patient received pneumococcal vaccine before or after
splenectomy. The splenectomy did nor accelerate the natural
course of the disease.
The frequency of the gene for Gaucher's disease in the Cape
Coloured community approximates that seen in the Afrikaner
population. In view of the severity of the condition in the
coloured population, this genetic situation has important impli-
cations. Antenatal diagnosis is possible and genetic counselling
must be made available to any coloured couple who have an
affected child. The diagnosis of this disorder should be con-
sidered in any coloured child who presents with unexplained
hepatosplenomegaly.
The authors wish to thank Professor P. Beighton for advice and
Dr H. J. Roelofse for referring patients.
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